“ “The UK and Europe are good markets, and we make sure we knock on the right doors with an appropriate value proposition. If we can create… ”
In Conversation
“ “As well as disease diagnosis, there is a lot that can be done around disease and therapy management using DNA data. For example, management of drug… ”
“ “We recently announced a partnership with Complement Pharmaceuticals to co-develop a complement inhibitor for neurodegenerative disorders, and our recent acquisition of Wilson Therapeutics fits perfectly within… ”
With over 30 years of experience in the life sciences industry, Angela McFarlane explains why the UK will not be removed from its position in the…
“ The UK is in itself a global life sciences hub and looked up to by the rest of the world. We have here the opportunity for… ”
“ I see technology as the enabler that creates new possibilities. Imaging devices are becoming more and more sophisticated and portable ”
“ We also collaborate on workshops with industry. There is a fundamental need to educate professionals about treatments and generate awareness of the patient view, and through… ”
“ It is this kind of contribution that has accelerated us to number five on the pharma UK rankings but quite frankly, working hard every day to… ”
“ “ The complexities in cancer treatment and care are myriad. That said, I firmly believe that we can collectively turn current challenges into opportunities towards improved… ”
“ “The UK is an international bridge and provides access to Europe, America and Asia. Its Commonwealth history and global presence have substantial advantages. Besides its location… ”
“ “Our affiliate tripled its activity in R&D in last 3 years: going from 8 studies in 2015 to 18 in 2018 and we have also increased… ”
“ “In order to be successful, you have to work hard with persistence, devotion, mutual support and harmonious cooperation of with all managers and personnel, towards our… ”
